rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
1
|
pubmed:dateCreated |
1998-3-12
|
pubmed:abstractText |
1. The effect of the acute or chronic oral administration of miglitol (Bay M 1099 alpha-glucosidase inhibitor) to non-insulin-dependent diabetic rats was studied. 2. The acute oral administration of miglitol (10 mg/kg b.w.) reduced significantly the increment of blood glucose after oral maltose (2 g/kg b.w.) overload (364 +/- 58 and 205 +/- 12 mmol/90 min, without and with miglitol respectively; P < 0.05). 3. Under chronic oral administration of miglitol (10 mg/kg b.w.), two days after the start of treatment the blood glucose dropped from 7.53 +/- 9.59 to 4.40 +/- 5.50 mmol/l. The plasma insulin, cholesterol, or triglycerides levels were not modified. 4. A significant reduction (P < 0.01) in water and food intake was observed. Normal rats values were not affected by miglitol treatment.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
0306-3623
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
30
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
125-9
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:9457493-1-Deoxynojirimycin,
pubmed-meshheading:9457493-Administration, Oral,
pubmed-meshheading:9457493-Animals,
pubmed-meshheading:9457493-Blood Glucose,
pubmed-meshheading:9457493-Diabetes Mellitus, Type 2,
pubmed-meshheading:9457493-Drug Administration Schedule,
pubmed-meshheading:9457493-Enzyme Inhibitors,
pubmed-meshheading:9457493-Glucosamine,
pubmed-meshheading:9457493-Hypoglycemic Agents,
pubmed-meshheading:9457493-Imino Pyranoses,
pubmed-meshheading:9457493-Male,
pubmed-meshheading:9457493-Rats,
pubmed-meshheading:9457493-Rats, Wistar
|
pubmed:year |
1998
|
pubmed:articleTitle |
Effect of miglitol administration to non-insulin-dependent diabetic rats.
|
pubmed:affiliation |
Departamento de Fisiologia, Facultad de Medicina, Universidad de Extremadura Apartado, Badajoz, Spain.
|
pubmed:publicationType |
Journal Article
|